J&J slashes third-quarter profit by $3 billion over proposed opioid deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein
October 25, 2019 8:48 AM EDTBernstein analyst Lee Hambright highlights that Johnson & Johnson (NYSE: JNJ) has lost $23 billion in market cap since October 18th, when the company announced a voluntary baby powder recall (33,000 bottles) after the FDA found asbestos at 0.00002% concentration in a sample from a single bottle purchased... More
